Z-ATAD-FMK, Caspase-12 inhibitor (ab141383)
Key features and details
- Caspase-12 inhibitor
- CAS Number:
- Purity: > 95%
- Soluble in DMSO to 20 mM
- Form / State: Lyophilized
- Source: Synthetic
製品の概要
-
製品名
Z-ATAD-FMK, Caspase-12 inhibitor -
製品の詳細
Caspase-12 inhibitor -
精製度
> 95% -
特記事項
This product is manufactured by BioVision, an Abcam company and was previously called 1152 ATAD-FMK, Z-,. 1152-5 is the same size as the 5 mg size of ab141383.
-
構造式
製品の特性
-
分子量
540.54 -
分子式
C24H33N4O9F -
配列
ATAD (Modifications: N-terminal benzyloxycarbonyl; C-terminal FMK; Asp-4 = Asp(OMe)) -
保存方法
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
溶解性
Soluble in DMSO to 20 mM -
使用に関する注意
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
由来
Synthetic
-
研究分野
関連製品
-
Related Products
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (2)
ab141383 は 2 報の論文で使用されています。
- Han J et al. Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells. Front Pharmacol 13:959938 (2022). PubMed: 36091790
- Wang J et al. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission. Redox Biol 30:101415 (2020). PubMed: 31901590